No causal role for the G482T and G689T polymorphisms in translation regulation of serotonin transporter (SLC6A4) or association with attention-deficit-hyperactivity disorder (ADHD)
- PMID: 19429092
- DOI: 10.1016/j.neulet.2009.03.032
No causal role for the G482T and G689T polymorphisms in translation regulation of serotonin transporter (SLC6A4) or association with attention-deficit-hyperactivity disorder (ADHD)
Abstract
Purpose of the study: The G482T and G689T polymorphisms in the 3'-UTR of serotonin transporter (SLC6A4) are implicated in translational regulation and allelic variants may mediate susceptibility to attention-deficit-hyperactivity disorder (ADHD). Accordingly, we examined influence of allelic variation on stable secondary structure formation and on seed sequences necessary for microRNA-binding. Furthermore, 90 ADHD cases from India were genotyped for these markers and tested for association with ADHD.
Methods: The Mfold software was used for secondary structure predictions and miRNA-binding sequences were obtained from the PicTar database. Using a family-based study design we assessed genetic association by means of the haplotype-based haplotype relative risk (HHRR) and transmission disequilibrium test (TDT) statistics. With respect to G689T, previously published TDT data were included in pooled analysis.
Result: Secondary structure analysis reveals that G482, U482, G689 and U689 conformers are energetically similar. Unlike G482, the U482 change maps within a loop and this conformer differs in free energy by approximately 4.4kcal/mol. While G482T is proximal to various miRNA-binding sequences, it is not part of the seed sequence for any of them. Thus, G482T and G689T polymorphisms do not regulate SLC6A4 translation in cis. From the HHRR (chi(2)=0.860, p=0.353; R.R.=1.11; 95% C.I.=0.89-1.65 for G482T; chi(2)=0.902, p=0.342; R.R.=1.17; 95% C.I.=0.83-1.32 for G689T), TDT (chi(2)=1.33, p=0.25; O.R.=1.35; 95% C.I.=0.94-1.94 for G482T; chi(2)=1.45, p=0.23; O.R.=1.44; 95% C.I.=0.94-2.22 for G689T) and pooled TDT (chi(2)=0.52, p=0.47; O.R.=1.05; 95% C.I.=0.96-1.15) statistics we infer that these polymorphisms are not associated with risk of ADHD.
Similar articles
-
Evidence that variation at the serotonin transporter gene influences susceptibility to attention deficit hyperactivity disorder (ADHD): analysis and pooled analysis.Mol Psychiatry. 2002;7(8):908-12. doi: 10.1038/sj.mp.4001100. Mol Psychiatry. 2002. PMID: 12232786
-
Some ADHD polymorphisms (in genes DAT1, DRD2, DRD3, DBH, 5-HTT) in case-control study of 100 subjects 6-10 age.Neuro Endocrinol Lett. 2008 Apr;29(2):246-51. Neuro Endocrinol Lett. 2008. PMID: 18404133
-
[Study of susceptibility loci located within Xp11 in attention deficit hyperactivity disorder].Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2001 Jun;18(3):169-72. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2001. PMID: 11402442 Chinese.
-
Candidate gene studies of attention-deficit/hyperactivity disorder.J Clin Psychiatry. 2006;67 Suppl 8:13-20. J Clin Psychiatry. 2006. PMID: 16961425 Review.
-
Principles of haplotype mapping and potential applications to attention-deficit/hyperactivity disorder.Biol Psychiatry. 2005 Jun 1;57(11):1357-66. doi: 10.1016/j.biopsych.2005.01.005. Biol Psychiatry. 2005. PMID: 15950008 Review.
Cited by
-
Blood-Bourne MicroRNA Biomarker Evaluation in Attention-Deficit/Hyperactivity Disorder of Han Chinese Individuals: An Exploratory Study.Front Psychiatry. 2018 May 29;9:227. doi: 10.3389/fpsyt.2018.00227. eCollection 2018. Front Psychiatry. 2018. PMID: 29896131 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials